4.7 Article

Prediction and classification of ventricular arrhythmia based on phase-space reconstruction and fuzzy c-means clustering

期刊

COMPUTERS IN BIOLOGY AND MEDICINE
卷 142, 期 -, 页码 -

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.compbiomed.2021.105180

关键词

Ventricular arrhythmia; Prediction and classification; Phase space reconstruction; Fuzzy C-means clustering

向作者/读者索取更多资源

This paper proposes a novel method for predicting and classifying ventricular arrhythmias. The method has been validated using data from two open databases and showed promising results in terms of prediction time and accuracy. This method has the potential to advance technologies such as implantable cardioverter defibrillators and help prevent sudden cardiac death.
Background and objective: Prediction and classification of Ventricular Arrhythmias (VA) may allow clinicians sufficient time to intervene for stopping its escalation to Sudden Cardiac Death (SCD). This paper proposes a novel method for predicting VA and classifying its type, in particular, the fatal VA even before the event occurs. Methods: A statistical index J based on the combination of phase-space reconstruction (PSR) and box counting has been used to predict VA. The fuzzy c-means (FCM) clustering technique is applied for the classification of impending VA. Results: 32 healthy and 32 arrhythmic subjects from two open databases -PTB Diagnostic database (PTBDB) and CU Ventricular Tachyarrhythmia (CUDB) database respectively; were used to validate our proposed method. Our method showed average prediction time of approximately 5 min (4.97 min) for impending VA in the tested dataset while classifying four types of VA (VA without ventricular premature beats (VPBs), ventricular fibrillation (VF), ventricular tachycardia (VT), and VT followed by VF) with an average 4 min (approximately) before the VA onset, i.e., after 1 min of the prediction time point with average accuracy of 98.4%, a sensitivity of 97.5% and specificity of 99.1%. Conclusions: The results obtained can be used in clinical practice after rigorous clinical trial to advance technologies such as implantable cardioverter defibrillator (ICD) that can help to preempt the occurrence of fatal ventricular arrhythmia -a main cause of SCD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据